Digital therapeutic motion-based device
DeviceThis intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training
NCT Number: NCT06609317
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.
In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.
Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
University of South Florida, Tampa, Florida, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training
Time frame: From enrollment to 6 months postpartum
Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.
Time frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.
Contact information is provided by the study sponsor or research team.
Katie Propst, MD
CONTACT
Maha Al Jumaily, MBBS
CONTACT
University of South Florida
Other
Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population
Acronym: PEARL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07488455
Postpartum Pelvic Floor Function and Symptoms
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT07228806
Postpartum Pelvic Floor Function and Symptoms
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT06896500
Flatulence, Flatus
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02512016
Postpartum Pelvic Floor Function and Symptoms
Salt Lake City, Utah, United States
View Trial Details